- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06431698
CORRECTION OF EAR DEFORMITIES IN NEWBORNS BY MODELING, COMPARISON OF TWO PROTOCOLS (MOLDEAR)
May 22, 2024 updated by: University Hospital, Caen
Evaluation of the non-inferiority of the custom-made device developed in the maxillofacial surgery department of Caen University Hospital compared to the device from the EarWell™ group
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
134
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alexis VEYSSIERE
- Phone Number: +33 +33231063106
- Email: drci-secretariat@chu-caen.fr
Study Contact Backup
- Name: VEYSSIERE
- Email: drci-secretariat@chu-caen.fr
Study Locations
-
-
N
-
Caen, N, France, 14000
- Recruiting
- Caen University Hospital
-
Contact:
- Alexis VEYSSIERE
- Phone Number: +33 +33231063106
- Email: drci-secretariat@chu-caen.fr
-
Contact:
- Alexis VEYSSIERE, MD
-
Principal Investigator:
- Alexis VEYSSIERE, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Newborn, age between 8 days and 1 month
- newborn with ear malformation
Exclusion Criteria:
- Total chondrocutaneous agenesis of the ear
- polymalformative syndrome
- age greater than 4 weeks
- parental refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
Correction of deformation using the adjustable Earwell device
|
Correction of deformation using the adjustable Earwell device
|
|
Experimental: Intervention group
Correction of deformation using the custom-made silicone device
|
Correction of deformation using the custom-made silicone device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective ear deformation score
Time Frame: baseline and 1 year after
|
Evaluation of the non-inferiority of the custom-made device developed in the maxillofacial surgery department of Caen University Hospital compared to the device from the EarWell™ group.
|
baseline and 1 year after
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 31, 2023
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
July 31, 2025
Study Registration Dates
First Submitted
May 22, 2024
First Submitted That Met QC Criteria
May 22, 2024
First Posted (Actual)
May 28, 2024
Study Record Updates
Last Update Posted (Actual)
May 28, 2024
Last Update Submitted That Met QC Criteria
May 22, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-0023 (Other Grant/Funding Number: DMID reference)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ear Malformation
-
Nemours Children's ClinicRecruitingMicrotia | Ear Cartilage | Microtia-Anotia | Microtia, Congenital | Ear Deformities, Acquired | Ear Deformity External | Ear MalformationUnited States
-
Ain Shams UniversityRecruitingOrbital Lymphatic MalformationEgypt
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Mayo Clinic; The University of... and other collaboratorsCompletedSyringomyelia | Arnold-Chiari Malformation, Type 1 | Chiari Malformation Type I | Type I Arnold-Chiari MalformationUnited States
-
I.R.C.C.S. Fondazione Santa LuciaIRCCS National Neurological Institute "C. Mondino" FoundationRecruitingCerebellar Degeneration | Cerebellar MalformationItaly
-
Assiut UniversityRecruitingChiari Malformation, Type 1Egypt
-
University College, LondonUniversity College London Hospitals; Great Ormond Street Hospital for Children...Not yet recruitingChiari Malformation Type 2 | Myelomeningocele | Brain Malformation
-
Venthera, Inc., a BridgeBio companyTerminatedLymphatic Malformation | Venous Malformation | Venolymphatic MalformationUnited States
-
Hospital Israelita Albert EinsteinCompletedChiari Malformation Type 2 | Myelomeningocele | Meningomyelocele | Open Spina Bifida | Chiari Malformation With Spina BifidaBrazil
-
Centre Hospitalier Universitaire, AmiensActive, not recruitingCerebrospinal Fluid | Phase Contrast MRI | Type I Chiari Malformation | Cerebral Hemodynamic | Craniospinal HydrodynamicFrance
-
St. Joseph's Hospital and Medical Center, PhoenixCompleted
Clinical Trials on adjustable Earwell device
-
Rheon Medical SACompleted
-
RxSight, Inc.Completed
-
Edwards LifesciencesCompletedMitral Valve InsufficiencyItaly, Belgium
-
RxSight, Inc.Completed
-
RxSight, Inc.Completed
-
RxSight, Inc.CompletedCataract | AphakiaUnited States
-
RxSight, Inc.Enrolling by invitation
-
RxSight, Inc.Completed